Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decreasing Function01:27

Decreasing Function

290
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
290
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

3.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Factors Influencing Microbial Growth: pH01:29

Factors Influencing Microbial Growth: pH

1.2K
Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.2K
Factors Influencing Microbial Growth: Temperature01:27

Factors Influencing Microbial Growth: Temperature

1.2K
Microorganisms display remarkable adaptations, enabling them to thrive in diverse ecological niches across a wide range of temperatures. Temperature profoundly influences microbial growth by affecting enzymatic activity, membrane fluidity, and other cellular processes.Each microorganism operates within a specific temperature range defined by three cardinal points: minimum, optimum, and maximum. Below the minimum temperature, membranes lose fluidity, halting transport processes. Above the...
1.2K
Factors Influencing Microbial Growth: Osmolarity01:28

Factors Influencing Microbial Growth: Osmolarity

870
Osmolarity is the measure of solute concentration in a solution. It plays a critical role in determining water availability for organisms. Water moves across semipermeable membranes through osmosis, flowing from regions of lower solute concentration (more dilute) to regions of higher solute concentration (more concentrated).In high-solute environments, microbial cells lose water, leading to dehydration and inhibited growth. The extent to which water is available to microbes in such environments...
870
Decreased Body Temperature01:29

Decreased Body Temperature

1.1K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiological trends in viral CNS infections in a French university hospital from 2019 to 2024, as revealed by multiplex PCR testing of cerebrospinal fluid samples.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Respiratory syncytial virus (RSV) in older adults: from infection to outcomes - who gets sick, who gets hospitalized, who survives?

BMC infectious diseases·2026
Same author

Methylated circulating tumor DNA: technical challenges and clinical applications in non-small cell lung cancer patients-a narrative review.

Translational lung cancer research·2026
Same author

LDL-cholesterol calculation methods and their influence on the indications for cholesterol-lowering treatment.

Annales d'endocrinologie·2026
Same author

Toward a ready-to-use blood collection tube preventing direct oral anticoagulant-interference with routine coagulation assays.

Journal of thrombosis and haemostasis : JTH·2026
Same author

JC polyomavirus-encoded miRNA jcv-miR-J1-5p downregulates BK polyomavirus infection.

Antiviral research·2025

Related Experiment Video

Updated: Jan 31, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

10.2K

Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in

Corinne Godin1, Sandra Bodeau2, Zuzana Saidak1

  • 1Equipe CHIMERE, EA 7516, Université de Picardie Jules Verne, 80054 Amiens, France.

Oncology Reports
|December 21, 2018
PubMed
Summary

Sorafenib treatment for advanced hepatocellular carcinoma (HCC) may be predicted by decreases in serum amphiregulin (AREG) and vascular endothelial growth factor (VEGF) levels. Early detection of these changes indicates better patient survival and treatment efficacy.

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.8K
Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
05:56

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts

Published on: January 22, 2020

5.2K

Related Experiment Videos

Last Updated: Jan 31, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

10.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.8K
Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
05:56

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts

Published on: January 22, 2020

5.2K

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Molecular Biology

Background:

  • Sorafenib is a standard treatment for advanced hepatocellular carcinoma (HCC).
  • Predicting sorafenib efficacy with biomarkers is crucial but challenging.
  • Sorafenib's mechanism involves inhibiting protein homeostasis and global translation, potentially disrupting autocrine loops.

Purpose of the Study:

  • To investigate sorafenib's effect on amphiregulin (AREG) and vascular endothelial growth factor (VEGF) in HCC.
  • To evaluate AREG and VEGF as predictive biomarkers for sorafenib efficacy in HCC patients.

Main Methods:

  • Experiments utilized HCC cell lines and patient serum samples.
  • Techniques included ELISA, quantitative PCR, western blotting, and cytokine arrays.
  • Serum AREG and VEGF levels were measured in 55 advanced HCC patients treated with sorafenib.

Main Results:

  • Sorafenib reduced AREG, VEGF, and cytokine expression at transcriptional and post-transcriptional levels.
  • Decreased serum AREG and VEGF levels after 15 days of sorafenib correlated with improved overall and progression-free survival.
  • A decrease in AREG was identified as an independent prognostic indicator for overall survival.

Conclusions:

  • Sorafenib inhibits autocrine loops in HCC.
  • Early decreases in serum AREG or VEGF levels can predict sorafenib efficacy in HCC patients.
  • AREG and VEGF show promise as predictive biomarkers for sorafenib treatment in advanced HCC.